Origin Scientific is currently undertaking a 60 subject human pharmacokinetics (“PK”) study delivering CBD through oral/mucosal administration
Designed to measure differences in absorption patterns between iQ encapsulated CBD vs non-encapsulated CBD
It will provide data demonstrating that encapsulation with iQ leads to:
• faster uptake into the bloodstream - competing with smoking/vaping
• longer presence in the bloodstream - stays long past when you'd see dissapation when inhaling
• increased Bioavailability - Multiple times more of the CBD will find it's way into the bloodstream
This will be one of the only extensive human studies of it's kind providing hard scientific evidence about the advantages of our iQ Technology
Initial results on a smaller subset of our research data isconfirming what we already know from encapsulating and testing other products....it works
